Accurate adult ADHD diagnosis is essential for appropriate treatment and to prevent the personal and economic costs of missed or erroneous labeling, making the development of objective assessment tools a pressing priority for mental‑health care.
The video examines why diagnosing ADHD in adults remains a contentious and unresolved challenge, emphasizing that unlike pediatric assessments, there is no universally accepted gold‑standard test for adults.
Experts Dr. Jessica Rosenfeld and Dr. Renee Kerian explain that current criteria stem from childhood symptom profiles, which do not map neatly onto adult responsibilities such as sustained workplace focus. Adults often mask symptoms and carry shame, while co‑occurring conditions like anxiety blur the clinical picture. Standard neuropsychological batteries such as the WAIS/WISC reveal statistically significant but clinically modest deficits in working memory and processing speed, and questionnaires, though widely used, differ fundamentally from objective cognitive tests.
Rosenfeld notes that the WAIS was once thought to flag ADHD but the publisher now advises it only to rule out other disorders. Kerian highlights emerging EEG research, citing the beta‑theta power ratio—values above three have been linked to ADHD—but acknowledges mixed results and that the technology is not yet ready for routine diagnosis. A light‑hearted anecdote about Kerian testing his own EEG after a few drinks illustrates both the novelty and the current experimental status of the method.
The absence of a reliable adult ADHD biomarker forces clinicians to rely on imperfect composites of self‑report, informant questionnaires, and limited cognitive testing, risking both over‑ and under‑diagnosis. A validated objective tool, such as a refined EEG protocol, could streamline assessment, reduce stigma, and improve treatment alignment for the millions of adults navigating undiagnosed or misdiagnosed ADHD.
Comments
Want to join the conversation?
Loading comments...